Inovio COVID-19 Vaccine Uses Electricity to Drive DNA Into Body Cells
Story Highlights Inovio Pharmaceuticals has started Phase 1 testing of its experimental COVID-19 DNA vaccine in healthy volunteers. The U.S. biotech firm has already produced enough of the vaccine to support Phase 1 (immune system reactivity and safety) and Phase 2 (efficacy) testing and plans to have one million doses ready for distribution by the […]
Flu Vaccines Failing Seniors
Opinion | Ever since the U.S. Centers for Disease Control and Prevention (CDC) began recommending that all Americans six months of age and older get an annual flu shot, it’s been touted as the best method of preventing influenza. While it’s true that influenza is a highly infectious airborne disease, controversy exists over the use […]
A Vaccine for Coronavirus by Autumn?
There appears to be a consensus opinion among leading public health authorities that a coronavirus vaccine for COVID-19 would take at least 12-18 months to develop, test and be ready for market distribution. The projection assumes that an aggressive development schedule would produce a licensed vaccine proven safe and effective for use in humans no […]
Unprecedented Response to COVID-19 by Governments Prohibits Physical Contact and Cripples World Economy
After officials at the World Health Organization (WHO) declared on Mar. 11, 2020 that outbreaks of a mutated coronavirus (COVID-19)1 2 had become a global pandemic and urged countries to take strong action to stop its spread,3 4 the governments of countries representing one-third of the world’s population5 closed borders, restricted or halted travel between […]
COVID-19 Related Drug Shortage in U.S. Because China Supplies Most Ingredients
Story Highlights The FDA has reported its first drug shortage as a result of the COVID-19 outbreak in China. Many drug ingredients and finished drug products used in the U.S are sourced and manufactured in China. The possibility of potential drug shortages highlights the issue of how the U.S. is heavily reliant on China for […]
Adenovirus Based Coronavirus Vaccine Being Tested
Greffex, Inc., a privately-held, multinational genetic engineering company headquartered in Houston, Texas has announced that it has completed development of a vaccine for the COVID-19 coronavirus. The vaccine will now proceed to testing in laboratory animals under supervision by the U.S Food and Drug Administration (FDA) and regulatory agencies in China.1 Greffex Got $18.9M from […]